Fluifort Special Precautions

Mucolytic agents could induce bronchial obstruction in children below 2 years. Indeed, bronchial mucus drainage capability is limited in this age because of the physiologic features of the respiratory tract.
They should not be used in children below 2 years.
No tolerance or dependence phenomena are known.
This product should not be administered to patients with rare inherited problems of glucose intolerance, glucose-galactose malabsorption, or insufficiency of the saccharose-isomaltase enzyme.
The product contains methyl-para-hydroxybenzoate, known to possibly cause urticaria. Para-hydroxybenzoates may generally cause delayed reactions, such as contact dermatitis, and they may rarely cause immediate reactions with manifestations of urticaria and bronchospasm.
Fluifort 90 mg/ml syrup does not contain gluten; therefore, it may be administered to patients suffering from celiac disease.
Fluifort 90 mg/ml syrup does not contain aspartame; therefore, it may be administered to patients suffering from phenylketonuria.
Patients with liver or kidney impairment: The normal dosage can be used.
Duration of treatment: FLUIFORT may be used for longer periods of time; in this case, physician's advice should be followed.
Effects of Ability to Drive and Use of Machinery: No negative effects of the drug on the ability to drive or use machines have been reported or can be assumed.